← Back
$RVMD All transactions

Revolution Medicines, Inc.

▼ SELL 10b5-1 Plan

$ Value

$210K

Shares

5,238

Price

$40

Filed

Sep 4

Insider

Name

Anders Jack

Title

Chief Financial Officer

CIK

0001800668

Roles

Officer

Transaction Details

Transaction Date

2025-09-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

113,314

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024. | Includes 54,213 RSUs. | This transaction was executed in multiple trades in prices ranging from $40.00 to $40.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. | This transaction was executed in multiple trades in prices ranging from $40.01 to $40.32, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Filing Info

Accession No.

0001610717-25-000326

Form Type

4

Issuer CIK

0001628171

Anders Jack's History

Date Ticker Type Value
2025-09-16 RVMD $106K
2025-09-03 RVMD M $15K
2025-09-03 RVMD M $35K
2025-09-03 RVMD $210K
2025-09-03 RVMD M $0
2025-09-03 RVMD M $0
2025-09-02 RVMD M $8K
2025-09-02 RVMD M $9K
2025-09-02 RVMD $191K
2025-09-02 RVMD M $0

Other Insiders at RVMD (90d)

Insider Bought Sold Last
GOLDSMITH MARK A
See Remarks
$18.0M 2026-04-15
Mancini Anthony
See Remarks
$3.6M 2026-03-25